BioNTech SE (BNTX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec18

BioNTech Completes Acquisition of CureVac to Enhance mRNA Capabilities

09:45

Dec12

Berenberg Raises BioNTech's Target Price to $155

07:16

Dec10

Citi Analyst Maintains Buy Rating on BioNTech SE

10:26

BioNTech Maintains Strong Buy Rating on Positive Lung Cancer Phase III Data

02:36

Dec9

BioNTech SE and Bristol Myers Squibb Report Positive Mid-Stage II Results for Pumitamig in Advanced Triple-Negative Breast Cancer

12:00

Dec6

BioNTech and OncoC4 Announce Phase III Clinical Trial Results of Gotistobart for Lung Cancer

20:30

Schedules & Filings

Schedules

Filings

Nov3

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.781 B, Net Income -33.66 M, EPS -0.1407

BioNTech SE (BNTX.US) Q3 2025 Earnings Conference Call

Aug4

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 305.28 M, Net Income -452.53 M, EPS -1.8728

BioNTech SE (BNTX.US) Q2 2025 Earnings Conference Call

May5

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 197.88 M, Net Income -450.1 M, EPS -1.8726

BioNTech SE (BNTX.US) Q1 2025 Earnings Conference Call

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change